One day prior to challenge, the organisms were subcultured to 50 ml of brain heart infusion (BHI) broth (BBL, Cockeysville, Md.). The fungi were incubated on a shaker at 37°C overnight, washed twice with 0.9% NaCl, quantified with a hemacytometer, and adjusted to the desired concentration in normal saline. The counts were verified by determining CFU counts with 10-fold serial dilutions in 0.9% NaCl. Each mouse was infected with 1.1 x 108 to 7 x 108 CFU/ml in the lateral tail vein given in a 0.2-ml volume. The T. glabrata cells were agitated between each injection to achieve a uniform suspension.Activity in vitro. The in vitro susceptibility studies were performed by the broth macrodilution technique proposed by the National Committee for Clinical Laboratory Standards (7). The medium was RPMI 1640 with glutamine, buffered by MOPS (morpholinepropanesulfonic acid) at pH 7.0 (American Bioganics, Niagara Falls, N.Y.). The inoculum was prepared from 24-h Sabouraud dextrose agar (Difco Laboratories, Detroit, Mich.) subcultures of T. glabrata incubated at 35°C. Colonies of T. glabrata were suspended in 5 ml of sterile distilled water, and the cell density was adjusted with a spectrophotometer to a 0.5 McFarland standard at a 530-nm wavelength. The working suspension was a 1:100 dilution of the organisms followed by a 1:20 dilution of the suspension with RPMI broth medium. A volume of 0.9 ml of the adjusted solution was dispensed into tubes containing 0.1 ml of 10 times the concentrations of the drugs to be tested. The test tubes were incubated at 35°C for 48 h.